A bill to amend XVIII of the Social Security Act to require certain manufacturers to report drug pricing information with respect to drugs under the Medicare program.
Strengthening Average Sales Price Reporting Act of 2019
This bill requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.
Placed on the Union Calendar, Calendar No. 571.
Placed on the Union Calendar, Calendar No. 170.
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Subcommittee Hearings Held.
Read twice and referred to the Committee on Finance.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Read twice and referred to the Committee on Finance.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line